SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fischer Medical Ventures incorporates subsidiary

17 Feb 2025 Evaluate

Fischer Medical Ventures has incorporated subsidiary namely Nanyang Biologics (India) on February 14, 2025. Nanyang Biologics (India) will engage in the business of manufacturing, formulating, importing, exporting, distributing, marketing, processing, and packaging of nutraceuticals, dietary supplements, functional foods, herbal supplements and other health related products for the promotion of human health. The company owns 51% of the shareholding in the new entity viz. Nanyang Biologics (India). 

Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.

Fischer Medical Share Price

34.73 1.04 (3.09%)
05-Jun-2026 09:25 View Price Chart
Peers
Company Name CMP
Redington 243.10
Amrapali Industries 18.55
Adani Enterprises 3003.50
Rashi Peripheral 540.60
PDS 321.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×